key: cord-0963499-uq9bopeu authors: Flores, Alex; Srinivasan, Visish M.; Seeley, Jill; Huggins, Charity; Kan, Peter; Burkhardt, Jan-Karl title: Safety, feasibility and patient-rated outcome of sonolucent cranioplasty in extracranial-intracranial (EC-IC) bypass surgery to allow for trans-cranioplasty ultrasound assessment. date: 2020-08-20 journal: World Neurosurg DOI: 10.1016/j.wneu.2020.08.114 sha: 285a99760a4f30671aad3a3fbf0fafa1aeace251 doc_id: 963499 cord_uid: uq9bopeu Abstract Objective To analyze the safety and feasibility of elective sonolucent cranioplasty in the setting of extra- to intracranial (EC-IC) bypass surgery to monitor bypass patency using ultrasound. Methods Patients who underwent direct EC-IC bypass surgery agreed to sonolucent cranioplasty at the time of surgery and received a sonolucent polymethyl methacrylate (PMMA) implant. Besides monitoring clinical outcome, all patients received trans-cranioplasty ultrasound (TCUS) on postoperative day 1 and at last follow-up. In addition, bypass patency was confirmed using catheter angiogram and fit of implant using computed tomography (CT). Patient-rated outcome was assessed through phone-questionnaire. Results EC-IC bypass surgery with PMMA cranioplasty was successful in all 7 patients with patent bypasses on postoperative angiogram. Direct TCUS was feasible in all patients and bypass patency was monitored. There were no complications such as postoperative hemorrhagic/ischemic complications related to the bypass procedure in this patient population as well as also no complications related to the PMMA implant. Postoperative CT showed favorable cosmetic result of the PMMA implant both in the pterional area for STA-MCA bypasses as well as the parieto-occipital area for OA-MCA bypasses as confirmed by high rated overall patient satisfaction with favorable cosmetic, pain and sensory patient-rated outcome. Conclusion In this study we were able to show that this novel technique is safe, allows for patency assessment of the EC-IC bypass using bedside TCUS technique and is cosmetically satisfying for patients. Direct surgical revascularization in the form of extracranial-intracranial (EC-IC) bypass surgery provides immediate therapeutic benefit in the treatment of stenotic or occluded intracranial arteries for different indications. 1,2 EC-IC bypass surgery is critical in the prevention of ischemic and/or hemorrhagic stroke across pathologies that characteristically display, or whose treatment may produce, diminished or obstructed cerebral blood flow such as Moyamoya disease, occlusive cerebrovascular disease, intracranial aneurysms, vessel injury, skull base tumors and others. [3] [4] [5] [6] [7] This technique involves the transcranial bridging of the external and internal carotid arteries via anastomosis of grafted or branching donor vessels, most commonly performed connecting the superficial temporal artery (STA) to the middle cerebral artery (MCA). 5, 8 While EC-IC bypass facilitates the instantaneous restoration of blood flow and opportunity for direct vessel network augmentation, postoperative monitoring of bypass patency is imperative to detect potential anastomosis complications. [9] [10] [11] [12] Conventional imaging modalities used include magnetic resonance angiography (MRA), computed-tomography angiography (CTA), and catheter-based digital subtraction angiography (DSA), however these techniques are time consuming, cannot be performed at the bedside, demand significant institutional resources, and expose the patient to additional risk in the form of radiation, contrast administration, and/or intravascular catheterization. For these reasons, alternative modalities are desired to optimize the safety, efficacy, and frequency of postoperative bypass imaging. Ultrasonography represents a burgeoning, readily available imaging modality that provides noninvasive, frequent, real-time monitoring without radiation exposure. While the attenuative properties of autologous cranial bone prohibit widespread transcranial ultrasound use, the use of postoperative ultrasound to monitor bypass patency has been described by measuring the flow of the donor artery before obscured by the bone flap when the donor artery dives J o u r n a l P r e -p r o o f intracranially to the anastomosis site. 9 However, neither the anastomosis nor the recipient cortical vessels are well visualized with this technique. The advantage of the recently FDA-approved polymethyl methacrylate (PMMA) cranioplasty implants (Longeviti Neuro Solutions, Hunt Valley, MD) is to overcome the obscured view through the skull and may therefore offer advantages as an adjunct for EC-IC bypass procedures. Although re-implanting the autologous bone flap is currently standard in EC-IC bypass, first-in-human feasibility assessment using this sonolucent PMMA cranioplasty implants (Longeviti Neuro Solutions, Hunt Valley, MD) has recently been described by our group with a favorable result. 13 Here, we build on the existing research by describing the first consecutive case series analyzing the safety, feasibility, and patient satisfaction of elective sonolucent cranioplasty in the setting of EC-IC bypass surgery for the use of postoperative trans-cranioplasty ultrasound (TCUS) in monitoring of bypass patency and blood flow. Data on EC-IC bypass patients with PMMA Clearfit cranioplasty from a single-surgeon, single center series were prospectively collected and retrospectively analyzed after IRB approval. Both the bypass procedure as well as the use of the PMMA cranioplasty implant, as opposed to the autologous bone flap, were discussed with the patient prior to surgery and written consent was obtained. For the EC-IC bypasses in this study, standard direct single-or double-barrel superficial temporal artery to middle cerebral artery (STA-MCA), occipital artery to middle cerebral artery Table 1 ). The survey took place at 2 months after surgery. The questions were modified based on a previous publication by Park et al. 14 In addition patients who had a bypass surgery before were asked to comment on overall cosmetic result compared to the PMMA implant. Seven patients underwent EC-IC bypass surgery with sonolucent cranioplasty at our hospitals between November 2019 and March 2020. The gender ratio was 1 male to 6 females. Two shapes of sonolucent PMMA implants were used in this series: 1) large, slightly curved piece used as raw material for cutting of a specific cranioplasty and 2) small, disc-shaped implant with greater curvature that could be used with minimal to no additional cutting or J o u r n a l P r e -p r o o f shaping (Figure 1 ). The latter is the product of surgeon-manufacturer collaboration to improve on the initial implant. The large implant was used in 4 patients (57%) and the small disc implant was used in 3 patients (43%). The large implant was used in both OA-involved surgeries (29%). Regardless of the size of initial implant, all fit well after they were shaped to the size of the cranial defect and achieved cosmetically favorable results both clinically and radiographically Patient-reported outcome based on a phone questionnaire was available in 6 patients (response rate 86%) and showed an excellent overall patient satisfaction rating for all (n=6, 100%) ( Table 2 ). Three of the 6 patients had a previous bypass surgery and rated the cosmetic result better (n=2) or the same (n=1). Pain or sensory complaints due to the cranioplasty was low and then another long-term FU study a few years later. The cranioplasty cost can range from $500 to several thousand dollars depending on size. 17 Since in this situation the smallest cranioplasty size is used (pre-made PMMA discs) the cost would be on the lower end. Notably, the cranioplasties are cost to the hospital and not the patient, unlike the imaging studies. For exclusive use of ultrasound for follow up imaging in this case, the cost to the patient for follow up imaging is approximately $900 (3 TCUS procedures). 18 Also, these TCUS can be billed in the neurosurgical clinic setting and are revenues for the neurosurgery department instead of CTA and catheter angiogram, which is billed through diagnostic radiology. We have described the first case series of elective cranioplasty for ultrasound imaging of EC-IC bypass, and demonstrated its safety, feasibility, and successful cosmetic outcome. Similar to our first published case, post-operative follow-ups to date indicate that there have been no implant-related complications to any patients across the performed bypass types. 13 The feasibility of TCUS has only recently been explored with the incidental findings that alloplastic cranioplasty implants possess sonolucent attributes conducive to ultrasonography. [19] [20] [21] Preliminary literature has displayed the value of using a sonolucent cranioplasty implant in monitoring a variety of intracranial variables, including ventricular size, hematoma, and cerebral blood flow and vessel patency. 13, 22 Being highly portable, and highly cost-effective, ultrasound imaging studies enable intra-and post-operative monitoring of longitudinal changes in patient vascularity and/or neurological condition, being readily performed in an outpatient setting allowing comparison to immediate post-operative baseline. Additionally, alloplastic cranial implants provide ideal cosmetic outcomes by circumventing resorption complications commonly associated with autologous bone flap replacement. 13, [23] [24] [25] However, while there is clear potential benefit to TCUS, widespread use of the technique has yet to be achieved, commensurate with the novelty of its application. Our patient-rated outcome showed favorable cosmetic results in this patient cohort. Although for EC-IC bypass the cranial defect is usually much smaller than in other patients requiring a cranioplasty the three patients who had previous (non-PMMA) bypass surgery rated their PMMA cranioplasty cosmetic result the same or even better. As shown in previous studies cosmetic results matter to the patients especially in the frontotemporal region. 14, 26 It has been shown that even a dent or irregularity of the cranioplasty may jeopardize the success of the J o u r n a l P r e -p r o o f surgery. 26 It was discovered that TCUS imaging may be painful within the first days after surgery, which is explained by the postoperative pain over the wound incision, and should be kept in mind when performed at bedside. Our data showed that during outpatient follow-up the was no more pain after recovery from surgery and that all patients enjoyed the opportunity to see the patent bypass together with the health care provider in real-time. For vascular neurosurgery TCUS with doppler has the potential to benefit both patient and providers in the future since it may add or replace invasive or x-ray based imaging modalities and provides the provider with instant information at bed side in real-time inpatient as well as in the outpatient setting. Besides direct EC-IC bypass surgeries, indirect revascularization with sonolucent cranioplasty may glean benefit in the ability to assess vascular collateralization over time using ultrasound imaging. While doing this technique the surgeon has to keep in mind that titanium plates used to fixate the PMMA implant as well as skin closure using staples may cause ultrasonic artifacts interfering with TCUS assessment. With more experience with this technique in the future we will be able to further optimize TCUS assessment as well as early detection of vascular complications at bedside. In addition, dural substitute use in patients assessed by TCUS is also an important topic and sonolucent quality of dural substitutes used after bypass surgery has not yet been systemically tested. With regards to the cost analysis as presented, elective PMMA cranioplasty may reduce costs for the patient if only TCUS instead of catheter angiogram / CTA is used. Also it is worth to mention that the cranioplasty itself is not charged to the patients, but to the hospital and that TCUS can be billed in the clinical setting by the neurosurgeon performing the TCUS, increasing revenue for the neurosurgery department. All these calculations are currently hypothetical, but as more experience and data of this techniques arise, this may be financially beneficial for the patient with reduced use of x-ray-based imaging modalities during follow up. While preliminary results are encouraging and opportunities for application are numerous, future research is necessary to better understand the reliability and efficacy of TCUS in both its present and prospective neurosurgical applications. Various limitations apply to this case series. All grafts were patent and therefore the ability of TCUS to identify graft failure or discriminate other flow compromise could not be thoroughly assessed given no failure group. Detection of minor flow changes in patent grafts also needs to be further assessed, specifically the detection of partial decrease in flow (such as by extrinsic compression, kinking) or spasm. Therefore, future work will aim to quantitatively assess patency via flow measurements, as done in Morton et. al with native bone flaps. 9 Further, while the results are promising, this case series represents preliminary work that will need to be built upon and updated. J o u r n a l P r e -p r o o f Surgical management of moyamoya disease: a review Monitoring flow in extracranial-intracranial bypass grafts using duplex ultrasonography: a single-center experience in 80 grafts over 8 years Superficial Temporal Artery: Distal Posterior Cerebral Artery Bypass through the Subtemporal Approach: Technical Note and Pilot Surgical Cases Bypass surgery for complex middle cerebral artery aneurysms: an algorithmic approach to revascularization Bypass in neurosurgery-indications and techniques Universal extracranial-intracranial graft bypass for large or giant internal carotid aneurysms: techniques and results in 38 consecutive patients Surgical results of the Carotid Occlusion Surgery Study Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article The use of ultrasound for postoperative monitoring of cerebral bypass grafts: A technical report Usefulness of intraoperative laser Doppler flowmetry and thermography to predict a risk of postoperative hyperperfusion after superficial temporal artery-middle cerebral artery bypass for moyamoya disease Delayed intracerebral hemorrhage after superficial temporal artery-middle cerebral artery anastomosis in a patient with moyamoya disease: possible involvement of cerebral hyperperfusion and increased vascular permeability Predictive factors for acute thrombogenesis occurring immediately after bypass procedure for moyamoya disease Elective Sonolucent Cranioplasty for Real-Time Ultrasound Monitoring of Flow and Patency of an Extra-to Intracranial Bypass Pterional versus superciliary keyhole approach: direct comparison of approach-related complaints and satisfaction in the same patient How Much Is That Head CT? Price Transparency and Variability in Radiology How Much Does an Angiogram Cost? CostHelper Comparative Cost Analysis of Single and Mutli-Stage Temporal Deformity Correction Following Neurosurgical Procedures Polymethyl Methacrylate Cranioplasty Is an Effective Ultrasound Window to Explore Intracranial Structures: Preliminary Experience and Future Perspectives Sonolucent Cranial Implants: Cadaveric Study and Clinical Findings Supporting Diagnostic and Therapeutic Transcranioplasty Ultrasound Polyether Ether Ketone Cranioplasties Are Permeable to Diagnostic Ultrasound Transcranioplasty Ultrasound Through a Sonolucent Cranial Implant Made of Polymethyl Methacrylate: Phantom Study Comparing Ultrasound, Computed Tomography, and Magnetic Resonance Imaging Classification of bone flap resorption after cranioplasty: a proposal for a computed tomography-based scoring system Aseptic bone-flap resorption after cranioplasty -incidence and risk factors Autologous Cranioplasty is Associated with Increased Reoperation Rate: A Systematic Review and Meta Aesthetic outcome in patients after polymethyl-methacrylate (PMMA) cranioplasty -a questionnaire-based single-centre study